POOL vs SPRY · P/E 18, rev $5.31B vs rev $89.1M
Pool Corporation (POOL) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Latest reported SPRY revenue for 2024-12-31 was $89.1M. Net income was $8.0M. Revenue was up 297063.3% from 2023-12-31 to 2024-12-31. SPRY currently screens at market cap $983.1M.
POOL currently screens at market cap $7.08B and trailing P/E 17.9. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the POOL and SPRY stock pages for the full models.
Not investment advice.